Search Results
Jeffrey L. Cummings, MD, ScD: Optimal Therapeutic Targets for Addressing Alzheimer Disease
Jeffrey L. Cummings, MD, ScD: Agitation, Psychosis in Alzheimer Disease
Jeffrey Cummings, MD, ScD: Repurposed Agents Within Alzheimer Disease Pipeline
Alzheimer'sWRAP - Jeffrey L. Cummings, MD
Jeffrey Cummings, MD, ScD: Greatest Unmet Needs in Alzheimer Disease
Jeffrey L Cummings – Monoclonal antibodies in the treatment of Alzheimer's disease
Silverado Medical Director Jeffrey Cummings, MD, ScD Discusses How to Identify Early Stage Dementia
Jeffrey Cummings discusses Drug Development & the Changing Alzheimer's Disease Therapeutic Landscape
Jeffrey Cummings, MD, ScD: Where Aducanumab Stands in Alzheimer Clinical Pipeline
Dr. Jeffrey Cummings - Alzheimer's Clinical Trials: History & Lessons
Progress for Alzheimer's Presentation: Dr. Jeffrey Cummings
Jeffrey Cummings, AAN 2019 – Emerging Alzheimer therapies and considerations for future research
